These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET. Liang Y; Feng Y; Zong M; Wei XF; Lee J; Feng Y; Li H; Yang GS; Wu ZJ; Fu XD; Feng GS Hepatology; 2018 May; 67(5):1807-1822. PubMed ID: 29152756 [TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma. Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103 [TBL] [Abstract][Full Text] [Related]
24. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. Haines K; Sarabia SF; Alvarez KR; Tomlinson G; Vasudevan SA; Heczey AA; Roy A; Finegold MJ; Parsons DW; Plon SE; López-Terrada D Pediatr Blood Cancer; 2019 Jul; 66(7):e27745. PubMed ID: 30977242 [TBL] [Abstract][Full Text] [Related]
25. Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability. Ueda Y; Hiyama E; Kamimatsuse A; Kamei N; Ogura K; Sueda T J Pediatr Surg; 2011 Dec; 46(12):2221-7. PubMed ID: 22152854 [TBL] [Abstract][Full Text] [Related]
26. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype. Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897 [TBL] [Abstract][Full Text] [Related]
27. LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC. Charawi S; Just PA; Savall M; Abitbol S; Traore M; Metzger N; Ravinger R; Cavard C; Terris B; Perret C J Pathol; 2019 Apr; 247(4):435-443. PubMed ID: 30566242 [TBL] [Abstract][Full Text] [Related]
28. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783 [TBL] [Abstract][Full Text] [Related]
29. Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma. Oversoe SK; Clement MS; Weber B; Grønbæk H; Hamilton-Dutoit SJ; Sorensen BS; Kelsen J BMC Cancer; 2021 Apr; 21(1):376. PubMed ID: 33827453 [TBL] [Abstract][Full Text] [Related]
31. CTNNB1 mutation suppresses infiltration of immune cells in hepatocellular carcinoma through miRNA-mediated regulation of chemokine expression. Xiao X; Mo H; Tu K Int Immunopharmacol; 2020 Dec; 89(Pt A):107043. PubMed ID: 33039961 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic characteristics of Wnt/β-catenin-deregulated hepatocellular carcinoma. Verma A; Bal M; Ramadwar M; Deodhar K; Patil P; Goel M Indian J Cancer; 2017; 54(4):634-639. PubMed ID: 30082549 [TBL] [Abstract][Full Text] [Related]
33. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. Xia H; Ooi LL; Hui KM PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603 [TBL] [Abstract][Full Text] [Related]
34. Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma. Akasu M; Shimada S; Kabashima A; Akiyama Y; Shimokawa M; Akahoshi K; Kudo A; Yamaoka S; Tanabe M; Tanaka S Sci Rep; 2021 Aug; 11(1):16732. PubMed ID: 34429454 [TBL] [Abstract][Full Text] [Related]
35. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin. Tao J; Xu E; Zhao Y; Singh S; Li X; Couchy G; Chen X; Zucman-Rossi J; Chikina M; Monga SP Hepatology; 2016 Nov; 64(5):1587-1605. PubMed ID: 27097116 [TBL] [Abstract][Full Text] [Related]
36. Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus. Rogacki K; Kasprzak A; Stępiński A Pol J Pathol; 2015 Mar; 66(1):9-21. PubMed ID: 26017875 [TBL] [Abstract][Full Text] [Related]